Posted by Michael Wonder on 01 Mar 2023
Nexus Pharmaceuticals receives FDA approval for Emerphed (ephedrine sulphate injection) pre-filled syringe
1 March 2023 - Nexus Pharmaceuticals announced that it has received US FDA approval for Emerphed (ephedrine sulphate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes.
The 10 mL presentation is the first and only FDA approved ready to administer 10 mL pre-filled syringe available.
